{
  "id": "ebaf6970775941f9",
  "title": "Johnson & Johnson New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner - Johnson & Johnson ( NYSE : JNJ ) ",
  "description": "20260217T173000Z",
  "content": "",
  "source": "benzinga.com",
  "source_url": "https://www.benzinga.com/news/fda/26/02/50658622/johnson-johnsons-new-fda-approval-lets-lung-cancer-patients-switch-to-monthly-dosing-sooner",
  "published_at": "20260217T173000Z",
  "fetched_at": "2026-02-18T00:30:07.542614+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.benzinga.com/news/fda/26/02/50658622/johnson-johnsons-new-fda-approval-lets-lung-cancer-patients-switch-to-monthly-dosing-sooner",
    "url_mobile": "",
    "title": "Johnson & Johnson New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner - Johnson & Johnson ( NYSE : JNJ ) ",
    "seendate": "20260217T173000Z",
    "socialimage": "https://cdn.benzinga.com/files/images/story/2026/02/17/Doctor-Hand-Point-Patient-Lung-X-ray-Fil.jpeg?&fit=crop",
    "domain": "benzinga.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}